Blog
RSS FeedPosted by Michael Wonder on 22 Dec 2023
PBS Expenditure and Prescriptions Report 2022-23
22 December 2023 - The PBS Expenditure and Prescriptions Report 1 July 2022 to 30 June 2023 is now available. ...
Posted by Michael Wonder on 16 Dec 2023
Report on the collection of under co-payment data 2022-23
15 December 2023 - The report on the collection of under co-payment data 2022-23 is now available. ...
Posted by Michael Wonder on 05 Dec 2023
ICER releases draft evidence report on treatment for paroxysmal nocturnal haemoglobinuria
5 December 2023 - Public comment period now open until 9 January 2024; requests to make oral comment during public ...
Posted by Michael Wonder on 04 Dec 2023
PHARMAC publishes minutes from August 2023 PTAC meeting
3 December 2023 - The meeting was held on 17-18 August 2023. After looking at the agenda, one asks why did ...
Posted by Michael Wonder on 28 Nov 2023
ICER releases draft evidence report on treatment for schizophrenia
28 November 2023 - Public comment period now open until 22 December 2023; requests to make oral comment during public meeting ...
Posted by Michael Wonder on 16 Nov 2023
Updates to the HTA Policy and Methods Review Reference Committee (16 November 2023)
16 November 2023 - Two more documents are now available. ...
Posted by Michael Wonder on 14 Nov 2023
ICER publishes evidence report on treatment for pulmonary arterial hypertension
14 November 2023 - Sotatercept added to background therapy appears to improve clinical outcomes, but there are uncertainties on long ...
Posted by Michael Wonder on 14 Nov 2023
DUSC utilisation analysis public release documents (June 2023)
14 November 2023 - The utilisation analysis public release documents from the June 2023 DUSC meeting are now available. ...
Posted by Michael Wonder on 13 Nov 2023
Outcome statement - September 2023 DUSC meeting
13 November 2023 - The Outcome Statement from the September 2023 DUSC meeting is now available. ...
Posted by Michael Wonder on 10 Nov 2023
Public Summary Documents – July 2023 PBAC meeting (round 2)
10 November 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2023 ...
Posted by Michael Wonder on 09 Nov 2023
Updates to the HTA Policy and Methods Review Reference Committee (9 November 2023)
9 November 2023 - Two more documents are now available. ...
Posted by Michael Wonder on 30 Oct 2023
ICER publishes final evidence report on gene therapy for metachromatic leukodystrophy
30 October 2023 - Independent appraisal committee voted that across all patient sub-populations, arsa-cel demonstrated a net health benefit when ...
Posted by Michael Wonder on 27 Oct 2023
Public Summary Documents – July 2023 PBAC meeting
27 October 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2023 PBAC ...
Posted by Michael Wonder on 25 Sep 2023
ICER releases draft evidence report on treatment for pulmonary arterial hypertension
25 September 2023 - Registration now open for 5 October “Early Insights” webinar. ...
Posted by Michael Wonder on 14 Sep 2023
ICER publishes evidence report on gene therapy for metachromatic leukodystrophy
14 September 2023 - Using weighted analyses across all patient subpopulations, atidarsagene autotemcel would achieve common thresholds for cost effectiveness if priced ...